Noonberg Sarah B.

Noonberg Sarah B. is listed in filings as Director at Neurogene Inc.. This profile follows SEC Form 4 activity through Feb 24, 2026, including sale activity. Recent filings connect the profile to Neurogene Inc. (NGNE) and Metagenomi, Inc. Common Stock (MGX). The current snapshot covers public activity from Jun 17, 2024 to Feb 24, 2026. Reported amounts are shown as $212.6K to $9.2K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.